Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1976 Feb 7;1(6005):323–328. doi: 10.1136/bmj.1.6005.323

The treatment of malaria.

A P Hall
PMCID: PMC1638678  PMID: 764937

Abstract

At least four doses of quinine followed by a single dose of mefloquine or by a single dose of sulfadoxine-pyrimethamine are two highly effective regimens for chloroquine-resistant falciparum malaria. Mefloquine alone is valuable in ambulant patients. Chloroquine-sensitive falciparum malaria can be treated with a course of chloroquine. Vivax and all other types of malaria should be treated with sequential chloroquine and primaquine. Quinine, by intravenous infusion, is the most effective drug for severe falciparum malaria. The optimum intravenous dose varies between 5 mg/kg and 10 mg/kg administered over four hours. Intravenous or oral quinine should be administered about every 12 hours and the total daily dose of quinine should rarely exceed 20 mg/kg. Intravenous fluid input should be controlled in falciparum malaria to prevent pulmonary oedema. Established renal failure is best treated by dialysis. The value of adrenocortical steroids for falciparum coma has not been established. Fresh blood transfusion may be helpful in small doses for severe anaemia and to replace clotting factors. Anticoagulants, such as heparin, should not be used in falciparum malaria.

Full text

PDF
323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adner M. M., Altstatt L. B., Conrad M. E. Coombs'-positive hemolytic disease in malaria. Ann Intern Med. 1968 Jan;68(1):33–38. doi: 10.7326/0003-4819-68-1-33. [DOI] [PubMed] [Google Scholar]
  2. Ansdell V. E., Boosey C. M., Geddes A. M., Morgan H. V. Malaria in Birmingham 1968-73. Br Med J. 1974 Apr 27;2(5912):206–208. doi: 10.1136/bmj.2.5912.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett-Connor E. Chemoprophylaxis of malaria for travelers. Ann Intern Med. 1974 Aug;81(2):219–224. doi: 10.7326/0003-4819-81-2-219. [DOI] [PubMed] [Google Scholar]
  4. Beale P. J., Cormack J. D., Oldrey T. B. Thrombocytopenia in malaria with immunoglobulin (IgM) changes. Br Med J. 1972 Feb 5;1(5796):345–349. doi: 10.1136/bmj.1.5796.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berger M., Birch L. M., Conte N. F. The nephrotic syndrome secondary to acute glomerulonephritis during falciparum malaria. Ann Intern Med. 1967 Dec;67(6):1163–1171. doi: 10.7326/0003-4819-67-6-1163. [DOI] [PubMed] [Google Scholar]
  6. Bhamarapravati N., Boonpucknavig S., Boonpucknavig V., Yaemboonruang C. Glomerular changes in acute plasmodium falciparum infection. An immunopathologic study. Arch Pathol. 1973 Nov;96(5):289–293. [PubMed] [Google Scholar]
  7. Blount R. E., Jr Acute falciparum malaria. Field experience with quinine-pyrimethamine combined therapy. Ann Intern Med. 1969 Jan;70(1):142–147. doi: 10.7326/0003-4819-70-1-142. [DOI] [PubMed] [Google Scholar]
  8. Borochovitz D., Crosley A. L., Metz J. Disseminated intravascular coagulation with fatal haemorrhage in cerebral malaria. Br Med J. 1970 Jun 20;2(5711):710–710. doi: 10.1136/bmj.2.5711.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brooks M. H., Malloy J. P., Bartelloni P. J., Tigertt W. D., Sheehy T. W., Barry K. G. Pathophysiology of acute falciparum malaria. I. Correlation of clinical and biochemical abnormalities. Am J Med. 1967 Nov;43(5):735–744. doi: 10.1016/0002-9343(67)90115-5. [DOI] [PubMed] [Google Scholar]
  10. Bruce-Chwatt L. J. Resistance of P. falciparum to chloroquine in Africa: true or false? Trans R Soc Trop Med Hyg. 1970;64(5):776–784. doi: 10.1016/0035-9203(70)90022-2. [DOI] [PubMed] [Google Scholar]
  11. COVELL G. Spontaneous rupture of the spleen. Trop Dis Bull. 1955 Aug;52(8):705–723. [PubMed] [Google Scholar]
  12. Canfield C. J., Keller H. I., Cirksena W. J. Erythrokinetics during treatment of acute falciparum malaria. Mil Med. 1971 Apr;136(4):354–357. [PubMed] [Google Scholar]
  13. Canfield C. J., Miller L. H., Bartelloni P. J., Eichler P., Barry K. G. Acute renal failure in Plasmodium falciparum malaria. Treatment of peritoneal dialysis. Arch Intern Med. 1968 Sep;122(3):199–203. [PubMed] [Google Scholar]
  14. Canfield C. J. Renal and hematologic complications of acute falciparum malaria in Vietnam. Bull N Y Acad Med. 1969 Oct;45(10):1043–1057. [PMC free article] [PubMed] [Google Scholar]
  15. Canfield C. J., Rozman R. S. Clinical testing of new antimalarial compounds. Bull World Health Organ. 1974;50(3-4):203–212. [PMC free article] [PubMed] [Google Scholar]
  16. Chipman M., Cadigan F. C., Jr, Benjapongse W. Involvement of the nervous system in malaria in Thailand. Trop Geogr Med. 1967 Mar;19(1):8–14. [PubMed] [Google Scholar]
  17. Colwell E. J., Hickman R. L., Kosakal S. Quinine-tetracycline and quinine-bactrim treatment of acute falciparum malaria in Thailand. Ann Trop Med Parasitol. 1973 Jun;67(2):125–132. doi: 10.1080/00034983.1973.11686870. [DOI] [PubMed] [Google Scholar]
  18. Data J. L., Nies A. S. Drugs five years later: dextran 40. Ann Intern Med. 1974 Oct;81(4):500–504. doi: 10.7326/0003-4819-81-4-500. [DOI] [PubMed] [Google Scholar]
  19. Deaton J. G. Fatal pulmonary edema as a complication of acute falciparum malaria. Am J Trop Med Hyg. 1970 Mar;19(2):196–201. doi: 10.4269/ajtmh.1970.19.196. [DOI] [PubMed] [Google Scholar]
  20. Deller J. J., Jr, Cifarelli P. S., Berque S., Buchanan R. Malaria hepatitis. Mil Med. 1967 Aug;132(8):614–620. [PubMed] [Google Scholar]
  21. Dennis L. H., Conrad M. E. Anticoagulant and antimalarial action of heparin in simian malaria. Lancet. 1968 Apr 13;1(7546):769–771. doi: 10.1016/s0140-6736(68)92225-3. [DOI] [PubMed] [Google Scholar]
  22. Dennis L. H., Eichelberger J. W., Inman M. M., Conrad M. E. Depletion of coagulation factors in drug-resistant Plasmodium falciparum malaria. Blood. 1967 May;29(5):713–721. [PubMed] [Google Scholar]
  23. Devakul K., Harinasuta T., Reid H. A. 125-I-labelled fibrinogen in cerebral malaria. Lancet. 1966 Oct 22;2(7469):886–888. doi: 10.1016/s0140-6736(66)91982-9. [DOI] [PubMed] [Google Scholar]
  24. Donadio J. V., Jr, Whelton A., Kazyak L. Quinine therapy and peritoneal dialysis in acute renal failure complicating malarial haemoglobinuria. Lancet. 1968 Feb 24;1(7539):375–379. doi: 10.1016/s0140-6736(68)91351-2. [DOI] [PubMed] [Google Scholar]
  25. Dukes D. C., Sealey B. J., Forbes J. I. Oliguric renal failure in blackwater fever. Am J Med. 1968 Dec;45(6):899–903. doi: 10.1016/0002-9343(68)90188-5. [DOI] [PubMed] [Google Scholar]
  26. Feldman H. A., Murphy F. D. THE EFFECT OF ALTERATIONS IN BLOOD VOLUME ON THE ANEMIA AND HYPOPROTEINEMIA OF HUMAN MALARIA. J Clin Invest. 1945 Nov;24(6):780–792. doi: 10.1172/JCI101664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Geddes T. G. Acute malaria in newborn infants. Br Med J. 1970 Sep 19;3(5724):711–711. doi: 10.1136/bmj.3.5724.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gilles H. M. Malaria in children. Br Med J. 1966 Dec 3;2(5526):1375–1377. doi: 10.1136/bmj.2.5526.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. HILL G. J., 2nd, KNIGHT V., JEFFERY G. M. THROMBOCYTOPENIA IN VIVAX MALARIA. Lancet. 1964 Feb 1;1(7327):240–241. doi: 10.1016/s0140-6736(64)92347-5. [DOI] [PubMed] [Google Scholar]
  30. HOCKWALD R. S., ARNOLD J., CLAYMAN C. B., ALVING A. S. Toxicity of primaquine in Negroes. J Am Med Assoc. 1952 Aug 23;149(17):1568–1570. doi: 10.1001/jama.1952.72930340027010c. [DOI] [PubMed] [Google Scholar]
  31. Hall A. P., Doberstyn E. B., Mettaprakong V., Sonkom P. Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine. Br Med J. 1975 Apr 5;2(5961):15–17. doi: 10.1136/bmj.2.5961.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hall A. P., Doberstyn E. B., Nanokorn A., Sonkom P. Falciparum malaria semi-resistant to clindamycin. Br Med J. 1975 Apr 5;2(5961):12–14. doi: 10.1136/bmj.2.5961.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hall A. P. Recrudescent falciparum malaria in Vietnam. Am J Trop Med Hyg. 1973 May;22(3):296–301. doi: 10.4269/ajtmh.1973.22.296. [DOI] [PubMed] [Google Scholar]
  34. Hall A. P., Segal H. E., Pearlman E. J., Phintuyothin P. Comparison of a 9-phenanthrene methanol (WR33063), a 4-quinoline methanol (WR30090), and quinine for falciparum malaria in Thailand. Trans R Soc Trop Med Hyg. 1975;69(3):342–349. doi: 10.1016/0035-9203(75)90129-7. [DOI] [PubMed] [Google Scholar]
  35. Hendrickse R. G., Adeniyi A., Edington G. M., Glasgow E. F., White R. H., Houba V. Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. Lancet. 1972 May 27;1(7761):1143–1149. doi: 10.1016/s0140-6736(72)91373-6. [DOI] [PubMed] [Google Scholar]
  36. Hendrickse R. G., Hasan A. H., Olumide L. O., Akinkunmi A. Malaria in early childhood. An investigation of five hundred seriously ill children in whom a "clinical" diagnosis of malaria was made on admission to the children's emergency room at University College Hospital, Ibadan. Ann Trop Med Parasitol. 1971 Mar;65(1):1–20. [PubMed] [Google Scholar]
  37. Howard W. A., Collins W. E. Heparin therapy in simian Plasmodium knowlesi malaria. Lancet. 1972 Oct 7;2(7780):738–739. doi: 10.1016/s0140-6736(72)92026-0. [DOI] [PubMed] [Google Scholar]
  38. Howard W. A., Krotoski W. A., Slonim M. S., Contacos P. G. Spontaneous splenic rupture in vivax malaria: case report. Mil Med. 1973 Jan;138(1):32–35. [PubMed] [Google Scholar]
  39. JACKSON R. C., WOODRUFF A. W. The artificial kidney in malaria and blackwater fever. Br Med J. 1962 May 19;1(5289):1367–1372. doi: 10.1136/bmj.1.5289.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Jaroonvesama N. Intravascular coagulation in falciparum malaria. Lancet. 1972 Jan 29;1(7744):221–223. doi: 10.1016/s0140-6736(72)90621-6. [DOI] [PubMed] [Google Scholar]
  41. Kibukamusoke J. W., Hutt M. S., Wilks N. E. The nephrotic syndrome in Uganda and its association with quartan malaria. Q J Med. 1967 Jul;36(143):393–408. [PubMed] [Google Scholar]
  42. Klein H. G., Bell W. R. Disseminated intravascular coagulation during heparin therapy. Ann Intern Med. 1974 Apr;80(4):477–481. doi: 10.7326/0003-4819-80-4-477. [DOI] [PubMed] [Google Scholar]
  43. Laing A. B. Malaria suppression with fortnightly doses of pyrimethamine with sulfadoxine in the Gambia. Bull World Health Organ. 1970;43(4):513–520. [PMC free article] [PubMed] [Google Scholar]
  44. Long D. M., Hartmann J. F., French L. A. The response of human cerebral edema to glucosteroid administration. An electron microscopic study. Neurology. 1966 May;16(5):521–528. doi: 10.1212/wnl.16.5.521. [DOI] [PubMed] [Google Scholar]
  45. Lucas A. O., Hendrickse R. G., Okubadejo O. A., Richards W. H., Neal R. A., Kofie B. A. The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine. Trans R Soc Trop Med Hyg. 1969;63(2):216–229. doi: 10.1016/0035-9203(69)90150-3. [DOI] [PubMed] [Google Scholar]
  46. Malloy J. P., Brooks M. H., Barry K. G. Pathophysiology of acute falciparum malaria. II. Fluid compartmentalization. Am J Med. 1967 Nov;43(5):745–750. doi: 10.1016/0002-9343(67)90116-7. [DOI] [PubMed] [Google Scholar]
  47. Miller L. H., Makaranond P., Sitprija V., Suebsanguan C., Canfield C. J. Hyponatraemia in malaria. Ann Trop Med Parasitol. 1967 Sep;61(3):265–279. doi: 10.1080/00034983.1967.11686487. [DOI] [PubMed] [Google Scholar]
  48. O'Holohan D. R., Hugoe-Matthews J. Malaria suppression and prophylaxis on a Malaysian rubber estate: sulformethoxine-pyrimethamine single monthly dose vs chloroquine single weekly dose. Southeast Asian J Trop Med Public Health. 1971 Jun;2(2):164–168. [PubMed] [Google Scholar]
  49. Ognibene A. J. Agranulocytosis due to dapsone. Ann Intern Med. 1970 Apr;72(4):521–524. doi: 10.7326/0003-4819-72-4-521. [DOI] [PubMed] [Google Scholar]
  50. Oriscello R. G. Cerebral malaria. Br Med J. 1968 Sep 7;3(5618):617–618. doi: 10.1136/bmj.3.5618.617-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Pearlman E. J., Hall A. P. Letter: Prevention of chloroquine-resistant falciparum malaria. Ann Intern Med. 1975 Apr;82(4):590–591. doi: 10.7326/0003-4819-82-4-590. [DOI] [PubMed] [Google Scholar]
  52. Petchclai R., Prasongsom S., Benjapongs W. Letter: Intravascular coagulation and malaria. Lancet. 1975 Jan 4;1(7897):36–36. doi: 10.1016/s0140-6736(75)92393-4. [DOI] [PubMed] [Google Scholar]
  53. Punyagupta S., Srichaikul T., Akarawong K. The use of heparin in fatal pulmonary edema due to acute falciparum malaria. J Med Assoc Thai. 1972 Feb;55(2):121–131. [PubMed] [Google Scholar]
  54. Reid H. A., Goldsmith H. J., Wright F. K. Peritoneal dialysis in acute renal failure following malaria. Lancet. 1967 Aug 26;2(7513):436–439. doi: 10.1016/s0140-6736(67)90853-7. [DOI] [PubMed] [Google Scholar]
  55. Reid H. A. Letter: Adjuvant treatment of severe falciparum malaria, intravascular coagulation, and heparin. Lancet. 1975 Jan 18;1(7899):167–168. doi: 10.1016/s0140-6736(75)91469-5. [DOI] [PubMed] [Google Scholar]
  56. Reid H. A., Nkrumah F. K. Fibrin-degradation products in cerebral malaria. Lancet. 1972 Jan 29;1(7744):218–221. doi: 10.1016/s0140-6736(72)90620-4. [DOI] [PubMed] [Google Scholar]
  57. Reid H. A., Sucharit P. Ancrod, heparin, and -aminocaproic acid in simian Knowlesi malaria. Lancet. 1972 Nov 25;2(7787):1110–1112. doi: 10.1016/s0140-6736(72)92716-x. [DOI] [PubMed] [Google Scholar]
  58. Sheehy T. W., Reba R. C. Complications of falciparum malaria and their treatment. Ann Intern Med. 1967 Apr;66(4):807–809. doi: 10.7326/0003-4819-66-4-807. [DOI] [PubMed] [Google Scholar]
  59. Skudowitz R. B., Katz J., Lurie A., Levin J., Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. Br Med J. 1973 Jun 2;2(5865):515–518. doi: 10.1136/bmj.2.5865.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Smith D. H., Harper P. S. Cerebral malaria. Br Med J. 1968 Sep 7;3(5618):618–618. doi: 10.1136/bmj.3.5618.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Smitskamp H., Wolthuis F. H. New concepts in treatment of malignant tertian malaria with cerebral involvement. Br Med J. 1971 Mar 27;1(5751):714–716. doi: 10.1136/bmj.1.5751.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Srichaikul T., Puwasatien P., Karnjanajetanee J., Bokisch V. A., Pawasatien P. Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria. Lancet. 1975 Apr 5;1(7910):770–772. doi: 10.1016/s0140-6736(75)92436-8. [DOI] [PubMed] [Google Scholar]
  63. Stuiver P. C., Ziegler J. L., Wood J. B., Morrow R. H., Hutt M. S. Clinical trial of malaria prophylaxis in tropical splenomegaly syndrome. Br Med J. 1971 Feb 20;1(5746):426–429. doi: 10.1136/bmj.1.5746.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tong M. J., Strickland G. T., Votteri B. A., Gunning J. J. Supplemental folates in the therapy of Plasmodium falciparum malaria. JAMA. 1970 Dec 28;214(13):2330–2333. [PubMed] [Google Scholar]
  65. Torrey E. F. Chloroquine seizures. Report of four cases. JAMA. 1968 Jun 3;204(10):867–870. doi: 10.1001/jama.204.10.867. [DOI] [PubMed] [Google Scholar]
  66. Trenholme C. M., Williams R. L., Desjardins R. E., Frischer H., Carson P. E., Rieckmann K. H., Canfield C. J. Mefloquine (WR 142,490) in the treatment of human malaria. Science. 1975 Nov 21;190(4216):792–794. doi: 10.1126/science.1105787. [DOI] [PubMed] [Google Scholar]
  67. Ward P. A., Kibukamusoke J. W. Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet. 1969 Feb 8;1(7589):283–285. doi: 10.1016/s0140-6736(69)91038-1. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES